Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoids and Schizophrenia: Risks and Therapeutic Potential
Marc W. Manseau, Donald Goff
Neurotherapeutics (2015) Vol. 12, Iss. 4, pp. 816-824
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9472-9472
Open Access | Times Cited: 204
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
Jerome Sarris, Justin Sinclair, Diana Karamacoska, et al.
BMC Psychiatry (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 203
Association of Genetic Liability to Psychotic Experiences With Neuropsychotic Disorders and Traits
Sophie E. Legge, Hannah Jones, Kimberley Kendall, et al.
JAMA Psychiatry (2019) Vol. 76, Iss. 12, pp. 1256-1256
Open Access | Times Cited: 138
Cannabidiol in the Treatment of Epilepsy
Randi von Wrede, Christoph Helmstaedter, Rainer Surges
Clinical Drug Investigation (2021) Vol. 41, Iss. 3, pp. 211-220
Open Access | Times Cited: 88
The therapeutic role of Cannabidiol in mental health: a systematic review
Rabia Khan, Sadiq Naveed, Nadeem Mian, et al.
Journal of Cannabis Research (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 78
Cannabidiol and epilepsy: Rationale and therapeutic potential
Antonio Leo, Emilio Russo, Maurizio Elia
Pharmacological Research (2016) Vol. 107, pp. 85-92
Closed Access | Times Cited: 70
An Atmospheric Pressure Chemical Ionization MS/MS Assay Using Online Extraction for the Analysis of 11 Cannabinoids and Metabolites in Human Plasma and Urine
Jost Klawitter, Cristina Sempio, Sophie Mörlein, et al.
Therapeutic Drug Monitoring (2017) Vol. 39, Iss. 5, pp. 556-564
Open Access | Times Cited: 63
The New Horizon of Antipsychotics beyond the Classic Dopaminergic Hypothesis—The Case of the Xanomeline–Trospium Combination: A Systematic Review
Octavian Vasiliu, Beatrice Budeanu, Mihai-Ștefan Cătănescu
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 610-610
Open Access | Times Cited: 6
Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes
Michelle R. Peace, Karen E. Butler, Carl E. Wolf, et al.
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 48
Capsaicin alleviates neuronal apoptosis and schizophrenia-like behavioral abnormalities induced by early life stress
Shilin Xu, Keke Hao, Ying Xiong, et al.
Schizophrenia (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Does KarXT (xanomeline-trospium) represent a novel approach to schizophrenia management? A GRADE-assessed systematic review and meta-analysis of randomized controlled clinical trials
Hazem Mohammed, M. Gomaa, Y. Khalifa, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research
Rafael Naime Ruggiero, Matheus Teixeira Rossignoli, Jana Batista De Ross, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 36
Analysis of endocannabinoids in plasma samples by biocompatible solid-phase microextraction devices coupled to mass spectrometry
Vinicius Ricardo Acquaro, Germán Augusto Gómez‐Ríos, Marcos Tascón, et al.
Analytica Chimica Acta (2019) Vol. 1091, pp. 135-145
Closed Access | Times Cited: 33
The link among microbiota, epigenetics, and disease development
Amr El-Sayed, Lotfi Aleya, Mohamed Kamel
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 23, pp. 28926-28964
Closed Access | Times Cited: 27
Exposotypes in Psychotic Disorders
Walid Yassin, Bryan Kromenacker, James Green, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
A review of Indian research on co-occurring cannabis use disorders& psychiatric disorders
Shalini Singh, Yatan Pal Singh Balhara
The Indian Journal of Medical Research (2017) Vol. 146, Iss. 2, pp. 186-195
Open Access | Times Cited: 30
Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions
Ferenc Zádor, Gábor Nagy-Grócz, Gabriella Kékesi, et al.
Molecules (2019) Vol. 24, Iss. 20, pp. 3709-3709
Open Access | Times Cited: 26
Cannabidiol Attenuates MK-801-Induced Cognitive Symptoms of Schizophrenia in the Passive Avoidance Test in Mice
Marta Kruk-Słomka, Grażyna Biała
Molecules (2021) Vol. 26, Iss. 19, pp. 5977-5977
Open Access | Times Cited: 22
Investigating Cannabidiol’s Potential as a Supplementary Treatment for Schizophrenia: A Narrative Review
Jes Sebastian Denis Völker, I. Micluția, Ramona-Cristina Vinași
European Journal of Pharmacology (2024) Vol. 979, pp. 176821-176821
Closed Access | Times Cited: 3
Prevalence and association of non-medical cannabis use with post-procedural healthcare utilisation in patients undergoing surgery or interventional procedures: a retrospective cohort study
Elena Ahrens, Luca J. Wachtendorf, Laetitia S Chiarella, et al.
EClinicalMedicine (2023) Vol. 57, pp. 101831-101831
Open Access | Times Cited: 7
Role of the endocannabinoid and endovanilloid systems in an animal model of schizophrenia-related emotional processing/cognitive deficit
Valéria de Almeida, Raquel Levin, Fernanda Fiel Peres, et al.
Neuropharmacology (2019) Vol. 155, pp. 44-53
Closed Access | Times Cited: 20
Determining Risks for Cannabis Use Disorder in the Face of Changing Legal Policies
Mackenzie Taylor, Janna Cousijn, Francesca M. Filbey
Current Addiction Reports (2019) Vol. 6, Iss. 4, pp. 466-477
Open Access | Times Cited: 20
Cannabis consumption and prosociality
Jacob M. Vigil, Sarah S. Stith, Tiphanie Chanel
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Stability of Tetrahydrocannabinol and Cannabidiol in Prepared Quality Control Medible Brownies
Carl E. Wolf, Justin L. Poklis, Alphonse Poklis
Journal of Analytical Toxicology (2016)
Open Access | Times Cited: 18
Differential effects of Δ9-tetrahydrocannabinol dosing on correlates of schizophrenia in the sub-chronic PCP rat model
Alexandre Seillier, Alex Martinez, Andrea Giuffrida
PLoS ONE (2020) Vol. 15, Iss. 3, pp. e0230238-e0230238
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top